A novel highly pathogenic Alzheimer presenilin-1 mutation in codon 117 (Pro117Ser): Comparison of clinical, neuropathological and cell culture phenotypes of Pro117Leu and Pro117Ser mutations

Topic: Amyloid, tau and blood-test diagnosis

A novel presenilin-1 (PS1) mutation (P117S) in an American pedigree is described. We compare clinical, neuropathological and cell culture phenotypes produced by this mutation with another codon 117 mutation that was earlier discovered by our group in a Polish kindred. Both mutations are associated with an unusually severe Alzheimer disease (AD) phenotype, with the onset starting before the third decade of life, rapid disease progression and acute presentation of clinical symptoms. The severity of clinical phenotype was closely correlated with the abundance of pathology: massive deposition of Abeta42 in plaques, severe neurofibrillary degeneration and neuronal loss. When overexpressed in mouse neuroblastoma N2a cells, both mutations caused loss of an ability to promote neurite outgrowth and produced an increase in the ratio of secreted Abeta42/40 amyloid peptides. In stably transfected N2a cell lines only mutant proteins were endoproteolytically cleaved indicating some dependability of this process on the presence of mutation. Taken together, our results show that clinical and cell culture phenotypes produced by these 2 codon 117 mutations are closely related suggesting that the pathogenic action of PS1 may involve effect on neurite outgrowth and endoproteolytic cleavage of the full-length protein. Given the high potency in vivo and in vitro of both codon 117 mutations, this site of PS1 must be particularly important for its normal/pathogenic function.

@article{dowjat2004-15004326,
  author  = {Dowjat, W. K. and Kuchna, I. and Wisniewski, T. and Wegiel, J.},
  title   = {{A novel highly pathogenic Alzheimer presenilin-1 mutation in codon 117 (Pro117Ser): Comparison of clinical, neuropathological and cell culture phenotypes of Pro117Leu and Pro117Ser mutations}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2004},
  doi     = {10.3233/jad-2004-6105},
  pmid    = {15004326},
  url     = {https://doi.org/10.3233/jad-2004-6105}
}

Key findings

• Both mutations are associated with an unusually severe Alzheimer disease (AD) phenotype, with the onset starting before the third decade of life, rapid disease progression and acute presentation of clinical symptoms.
• Taken together, our results show that clinical and cell culture phenotypes produced by these 2 codon 117 mutations are closely related suggesting that the pathogenic action of PS1 may involve effect on neurite outgrowth and endoproteolytic cleavage of the full-length protein.

New to this subject? Start with our plain-English guide: Blood tests & biomarkers →

Study details

• Evidence strengthLow

Read the original

• DOI: 10.3233/jad-2004-6105
• PubMed: 15004326
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Related studies in Biomarkers

• Highly pathogenic Alzheimer's disease presenilin 1 P117R mutation causes a specific increase in p53 and p21 protein levels and cell cycle dysregulation in human lymphocytes Journal of Alzheimer's disease : JAD · 2012-01-01 · usefulness score 36/100
• Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations Neurobiology of disease · 2020-02-04 · usefulness score 38/100
• Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase Proceedings of the National Academy of Sciences of the United States of America · 2016-12-05 · usefulness score 41/100
• Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation Neuroscience letters · 2010-11-19 · usefulness score 41/100
• PSEN2 Mutation Spectrum and Novel Functionally Validated Mutations in Alzheimer's Disease: Data from PUMCH Dementia Cohort Journal of Alzheimer's disease : JAD · 2022 · usefulness score 48/100
• A novel presenilin-1 mutation (Leu85Pro) in early-onset Alzheimer disease with spastic paraparesis Archives of neurology · 2004-11-01 · usefulness score 41/100

Also tagged “presenilin-1-mutations”

2 studies in the library carry the topic tag “presenilin-1-mutations”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 2 tagged studies.

• Two novel presenilin-1 mutations (I249L and P433S) in early onset Chinese Alzheimer's pedigrees and their functional characterization Biochemical and biophysical research communications · 2019-06-21 · usefulness score 43/100 · Biomarkers

Similar studies

• Aβ42/Aβ40 Ratios of Presenilin 1 Mutations Correlate with Clinical Onset of Alzheimer's Disease 2018 · Biomarkers
• A novel presenilin 2 mutation (V393M) in early-onset dementia with profound language impairment 2008 · Biomarkers
• The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology 1996 · Risk genes beyond APOE
• The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of Aβ in different brain regions 2010 · Biomarkers
• Mutations in amyloid precursor protein affect its interactions with presenilin/gamma-secretase 2009 · Biomarkers
• A novel presenilin 1 mutation (Ala275Val) as cause of early-onset familial Alzheimer disease 2014 · Tau biomarkers

More on Biomarkers

• A review that covers this ground Biomarkers of glial cell proliferation and differentiation in culture Frontiers in bioscience (Scholar edition) · 2010-01-01 · usefulness score 36/100
• Newest in this subject Longitudinal plasma biomarkers and multimodal PET across APOE ε4 genotypes: a prospective cohort study Research Square · 2026-11-01 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Concurrent cognitive, behavioral and systemic physiological features mark preclinical Alzheimer's disease bioRxiv · 2026-10-30 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Biomarkers →